Gates Foundation pledges $2.5B to women’s health research

Posted: 15 august 2025

The Gates Foundation said it is committing to invest $2.5 billion over the next five years to accelerate research and development in neglected areas of women’s health.

Lack of investment often slows the research necessary for biotechnology companies to develop new medicines, leaving common disorders such as endometriosis, polycystic ovary syndrome and preeclampsia without good treatment options.

Latest posts

Waystar makes $1.25B bet on AI for healthcare payments

Posted: 23 august 2025

Waystar has signed a definitive agreement to acquire Iodine Software, a $1.25 billion deal that seeks to empower healthcare payments with more AI capabilities. Read more here.

NICE approves new treatment for inflammatory bowel disease

Posted: 22 august 2025

Doctors will be able to prescribe a new treatment for people with inflammatory bowel disease (IBD), after the UK medicines watchdog approved guselkumab (Tremfya) for use on the NHS. Read more here.